Skip to content

EVOFEM BIOSCIENCES, INC.: filings

Every EVOFEM BIOSCIENCES, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 46 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q2 2026471280001493152-26-038328
10-Q2026-05-15fiscal Q1 202648960001493152-26-023928
10-K2026-03-11fiscal FY 2025501000001493152-26-009686
10-Q2025-11-13fiscal Q3 2025471320001493152-25-022275
10-Q2025-08-14fiscal Q2 2025471270001641172-25-023741
10-Q2025-05-15fiscal Q1 202547930001641172-25-010529
10-K2025-03-24fiscal FY 2024511010001641172-25-000188
10-Q2024-11-14fiscal Q3 2024491370001493152-24-046060
10-Q2024-08-14fiscal Q2 2024471310001493152-24-031846
10-Q2024-05-15fiscal Q1 202448970001493152-24-019428
10-K2024-03-27fiscal FY 2023501010001493152-24-011404
10-Q2023-11-14fiscal Q3 2023481340001493152-23-040764
10-Q2023-08-14fiscal Q2 2023471300001493152-23-028671
10-Q2023-06-16fiscal Q1 202343880001493152-23-021701
10-K2023-04-27fiscal FY 2022511040001618835-23-000023
10-Q2023-01-06fiscal Q3 2022461340001618835-23-000001
10-Q2022-08-12fiscal Q2 2022451280001618835-22-000166
10-Q2022-05-10fiscal Q1 202244920001618835-22-000110
10-K2022-03-10fiscal FY 2021501020001618835-22-000057
10-Q2021-11-15fiscal Q3 2021471370001618835-21-000240
10-Q2021-08-11fiscal Q2 2021451270001618835-21-000175
10-Q2021-05-06fiscal Q1 202141870001618835-21-000099
10-K2021-03-04fiscal FY 202044890001618835-21-000040
10-Q2020-11-09fiscal Q3 2020411150001618835-20-000242
10-Q2020-08-04fiscal Q2 202036980001618835-20-000216
10-Q2020-05-06fiscal Q1 202032690001618835-20-000105
10-K2020-03-12fiscal FY 2019381070001618835-20-000047
10-Q2019-11-07fiscal Q3 201935990001618835-19-000170
10-Q2019-08-06fiscal Q2 201934930001618835-19-000147
10-Q2019-05-07fiscal Q1 201933670001618835-19-000084
10-K2019-03-01fiscal FY 2018351030001618835-19-000031
10-Q2018-11-07fiscal Q3 201833870001618835-18-000105
10-Q2018-08-02fiscal Q2 201829790001618835-18-000061
10-Q2018-05-14fiscal Q1 201829590001618835-18-000027
10-K2018-02-26fiscal FY 201722530001564590-18-003259
10-Q2017-11-08fiscal Q3 201719510001564590-17-022496
10-Q2017-08-10fiscal Q2 201718470001564590-17-017119
10-Q2017-05-11fiscal Q1 201718370001564590-17-010425
10-K2017-03-23fiscal FY 201620500001564590-17-005093
10-Q2016-11-10fiscal Q3 201619490001564590-16-028810
10-Q2016-08-11fiscal Q2 201619490001564590-16-023997
10-Q2016-05-12fiscal Q1 201619390001564590-16-019174
10-K2016-03-29fiscal FY 201521520001564590-16-015451
10-Q2015-11-12fiscal Q3 201520520001564590-15-010461
10-Q2015-08-13fiscal Q2 201521530001564590-15-007166
10-Q2015-05-14fiscal Q1 201521430001564590-15-004240

Inspect the source

Entity
EVOFEM BIOSCIENCES, INC. / CIK 0001618835
Captured
2026-09-21T17:21:39.444Z
SEC response SHA-256
c8bf3bae341cb8de34e01a708b32050739ddc460f13010d7d1bd9abd1c4dd597

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001618835.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))